90 related articles for article (PubMed ID: 27279798)
1. 5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions.
Westre B; Giske A; Guttormsen H; Sørbye SW; Skjeldestad FE
BMC Clin Pathol; 2016; 16():9. PubMed ID: 27279798
[TBL] [Abstract][Full Text] [Related]
2. HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.
Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
PLoS One; 2014; 9(11):e112934. PubMed ID: 25405981
[TBL] [Abstract][Full Text] [Related]
3. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
4. HPV mRNA testing in triage of women with ASC-US cytology may reduce the time for CIN2+diagnosis compared with repeat cytology.
Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
Curr Pharm Des; 2013; 19(8):1401-5. PubMed ID: 23016772
[TBL] [Abstract][Full Text] [Related]
5. Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology.
Sørbye SW; Arbyn M; Fismen S; Gutteberg TJ; Mortensen ES
PLoS One; 2011; 6(8):e24083. PubMed ID: 21918682
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
[TBL] [Abstract][Full Text] [Related]
7. Liquid-based cytology with HPV triage of low-grade cytological abnormalities versus conventional cytology in cervical cancer screening.
Fröberg M; Norman I; Johansson B; Hjerpe A; Weiderpass E; Andersson S
Curr Pharm Des; 2013; 19(8):1406-11. PubMed ID: 23016773
[TBL] [Abstract][Full Text] [Related]
8. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
9. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
10. Aptima HPV Assay versus Hybrid Capture
Cook DA; Smith LW; Law J; Mei W; van Niekerk DJ; Ceballos K; Gondara L; Franco EL; Coldman AJ; Ogilvie GS; Jang D; Chernesky M; Krajden M
J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
12. Immediate referral to colposcopy versus cytological surveillance for low-grade cervical cytological abnormalities in the absence of HPV test: A systematic review and a meta-analysis of the literature.
Kyrgiou M; Kalliala I; Mitra A; Ng KY; Raglan O; Fotopoulou C; Martin-Hirsch P; Paraskevaidis E; Arbyn M
Int J Cancer; 2017 Jan; 140(1):216-223. PubMed ID: 27603593
[TBL] [Abstract][Full Text] [Related]
13. Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion triage in Korean women: Revisiting the 2012 American Society of Colposcopy and Cervical Pathology screening guidelines.
Hyun JY; Min KJ; Yang SY; Lee JK; Hong JH
Obstet Gynecol Sci; 2017 Jul; 60(4):357-361. PubMed ID: 28791267
[TBL] [Abstract][Full Text] [Related]
14. Relevance of HPV Screening for Triaging Equivocal Cytology Findings in the Pap II-p, Pap III and Pap IIID Groups - Results of Two Long-Term Studies.
Luyten A; Petry KU
Geburtshilfe Frauenheilkd; 2015 Oct; 75(10):1058-1062. PubMed ID: 26556908
[No Abstract] [Full Text] [Related]
15. Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology.
Wright TC; Stoler MH; Parvu V; Yanson K; Cooper C; Andrews J
Gynecol Oncol; 2019 Aug; 154(2):360-367. PubMed ID: 31160073
[TBL] [Abstract][Full Text] [Related]
16. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
[TBL] [Abstract][Full Text] [Related]
17. Clinical performance of the Cobas 4800 HPV test and the Aptima HPV assay in the management of women referred to colposcopy with minor cytological abnormalities.
Tewari P; White C; Kelly L; Pilkington L; Keegan H; D'Arcy T; Toole SO; Sharp L; O'Leary JJ; Martin CM
Diagn Cytopathol; 2018 Dec; 46(12):987-992. PubMed ID: 30284405
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
